Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Denton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Kidney International|January 30, 2019
Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?Roisin Connolly, Mark D Denton, Hilary Humphreys, et al.
Journal of Nephrology|July 13, 2002
Statin specific toxicity in organ transplant recipients: case report and review of the literatureJina Bae, John A Jarcho, Mark D Denton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantationJohn P Forman, Julie Lin, Manuel Pascual, et al.
Journal of Nephrology|May 25, 2002
DNA microarrays: applicability to renal physiology and diseaseMark D Denton, Takumi Yoshida, Li-Li Hsiao, et al.
Clinical Transplantation|July 6, 2004
Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipientsColm C Magee, Mark D Denton, Karl L Womer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2009
Early results of a controlled non-heart-beating kidney donor programmeJacob A Akoh, Mark D Denton, Sharon B Bradshaw, et al.
Transplantation|October 27, 2004
TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathyMark D Denton, Colm Magee, Michael Melter, et al.
Kidney International|May 25, 2002
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysisMark D Denton, Colm C Magee, Cyril Ovuworie, et al.
Clinical Nephrology|May 19, 2012
Effect of perioperative blood transfusions on long term graft outcomes in renal transplant patientsFrank J O'Brien, James Lineen, Claire M Kennedy, et al.
Nephrology (Carlton, Vic.)|June 5, 2013
Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in IrelandCarol A Traynor, Donal Tighe, Frank J O'Brien, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Kidney International|January 30, 2019
Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?Roisin Connolly, Mark D Denton, Hilary Humphreys, et al.
Journal of Nephrology|July 13, 2002
Statin specific toxicity in organ transplant recipients: case report and review of the literatureJina Bae, John A Jarcho, Mark D Denton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantationJohn P Forman, Julie Lin, Manuel Pascual, et al.
Journal of Nephrology|May 25, 2002
DNA microarrays: applicability to renal physiology and diseaseMark D Denton, Takumi Yoshida, Li-Li Hsiao, et al.
Clinical Transplantation|July 6, 2004
Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipientsColm C Magee, Mark D Denton, Karl L Womer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2009
Early results of a controlled non-heart-beating kidney donor programmeJacob A Akoh, Mark D Denton, Sharon B Bradshaw, et al.
Transplantation|October 27, 2004
TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathyMark D Denton, Colm Magee, Michael Melter, et al.
Kidney International|May 25, 2002
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysisMark D Denton, Colm C Magee, Cyril Ovuworie, et al.
Clinical Nephrology|May 19, 2012
Effect of perioperative blood transfusions on long term graft outcomes in renal transplant patientsFrank J O'Brien, James Lineen, Claire M Kennedy, et al.
Nephrology (Carlton, Vic.)|June 5, 2013
Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in IrelandCarol A Traynor, Donal Tighe, Frank J O'Brien, et al.
Pageof 2